CVS Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$67.40 |
| 52 Week High | US$80.80 |
| 52 Week Low | US$65.80 |
| Beta | 0.51 |
| 1 Month Change | -14.03% |
| 3 Month Change | -16.58% |
| 1 Year Change | -7.14% |
| 3 Year Change | -16.17% |
| 5 Year Change | n/a |
| Change since IPO | -1.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | PE Healthcare | PE Market | |
|---|---|---|---|
| 7D | -7.7% | 0% | 0% |
| 1Y | -7.1% | 0% | 0% |
Return vs Industry: CVS underperformed the PE Healthcare industry which returned 6.1% over the past year.
Return vs Market: CVS underperformed the PE Market which returned 10.1% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in PE Market | 0% |
| 10% least volatile stocks in PE Market | 0% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months.
Volatility Over Time: CVS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | US$85.35b |
| Earnings (TTM) | US$7.32b |
| Revenue (TTM) | US$359.78b |
9.7x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$359.78b |
| Cost of Revenue | US$307.32b |
| Gross Profit | US$52.46b |
| Other Expenses | US$45.14b |
| Earnings | US$7.32b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.81 |
| Gross Margin | 14.58% |
| Net Profit Margin | 2.03% |
| Debt/Equity Ratio | 86.5% |
How did CVS perform over the long term?
See historical performance and comparison